Literature DB >> 17325128

Mechanism of thiazolidinedione-dependent cell death in Jurkat T cells.

Mathias Soller1, Stefan Dröse, Ulrich Brandt, Bernhard Brüne, Andreas von Knethen.   

Abstract

Thiazolidinediones are synthetic agonists for the transcription factor peroxisome proliferator-activated receptor gamma (PPARgamma) and are therapeutically used as insulin sensitizers. Besides therapeutical benefits, potential side effects such as the induction of cell death by thiazolidinediones deserve consideration. Although PPARgamma-dependent and -independent cell death in response to thiazolidinediones has been described, we provide evidence supporting a new mechanism to account for thiazolidinedione-initiated but PPARgamma-independent cell demise. In Jurkat T cells, ciglitazone and troglitazone provoked rapid and dose-dependent cell death, whereas rosiglitazone did not alter cell viability. We found induction of apoptosis by troglitazone, whereas ciglitazone caused necrosis. Because preincubation with the reactive oxygen species (ROS) scavengers manganese (III) tetrakis(4-benzoic acid) porphyrin and vitamin C significantly inhibited ciglitazone- and partially troglitazone-mediated cell death, we suggest that ROS contribute to cytotoxicity. Assuming that ROS originate from mitochondria, studies in submitochondrial particles demonstrated that all thiazolidinediones inhibited complex I of the mitochondrial respiratory chain. However, only ciglitazone and troglitazone lowered complex II activity as well. Pharmacological inhibition of complexes I and II documented that complex II inhibition in Jurkat cells caused massive apoptotic cell death, whereas inhibition of complex I provoked only marginally apoptosis after 4-h treatment. Therefore, inhibition of complex II by ciglitazone and troglitazone is the main trigger of cell death. ATP depletion by ciglitazone, in contrast to troglitazone, is responsible for induction of necrosis. Our results demonstrate that despite their similar molecular structure, thiazolidinediones differently affect cell death, which might help to explain some adverse effects occurring during thiazolidinedione-based therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17325128     DOI: 10.1124/mol.107.034371

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  8 in total

1.  Conjugated linoleic acid-induced apoptosis in mouse mammary tumor cells is mediated by both G protein coupled receptor-dependent activation of the AMP-activated protein kinase pathway and by oxidative stress.

Authors:  Yung-Chung Hsu; Margot M Ip
Journal:  Cell Signal       Date:  2011-07-23       Impact factor: 4.315

2.  Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinoma.

Authors:  Alan Prem Kumar; Ser Yue Loo; Sung Won Shin; Tuan Zea Tan; Chon Boon Eng; Rajeev Singh; Thomas Choudary Putti; Chee Wee Ong; Manuel Salto-Tellez; Boon Cher Goh; Joo In Park; Jean Paul Thiery; Shazib Pervaiz; Marie Veronique Clement
Journal:  Antioxid Redox Signal       Date:  2013-11-14       Impact factor: 8.401

3.  Interaction of ligands for the peroxisome proliferator-activated receptor gamma with the endocannabinoid system.

Authors:  A Lenman; C J Fowler
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

4.  Alpha-tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II.

Authors:  L-F Dong; P Low; J C Dyason; X-F Wang; L Prochazka; P K Witting; R Freeman; E Swettenham; K Valis; J Liu; R Zobalova; J Turanek; D R Spitz; F E Domann; I E Scheffler; S J Ralph; J Neuzil
Journal:  Oncogene       Date:  2008-03-31       Impact factor: 9.867

5.  Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.

Authors:  Linah Al-Alem; R Chase Southard; Michael W Kilgore; Thomas E Curry
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

6.  Omega-3 Fatty Acids and PPARgamma in Cancer.

Authors:  Iris J Edwards; Joseph T O'Flaherty
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

7.  Pathophysiological Roles of PPARgamma in Gastrointestinal Epithelial Cells.

Authors:  Brian M Necela; E Aubrey Thompson
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

8.  PPARs in Irradiation-Induced Gastrointestinal Toxicity.

Authors:  Christine Linard; Maâmar Souidi
Journal:  PPAR Res       Date:  2009-11-22       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.